Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chemotherapy in the elderly].

H Furue1

  • 1Dept. of Internal Medicine IV, Teikyo University School of Medicine, Kawasaki, Japan.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|September 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Processing of CD109 by furin and its role in the regulation of TGF-beta signaling.

Oncogene·2010
Same author

Responses to 5-HT in morphologically identified neurons in the rat substantia gelatinosa in vitro.

Neuroscience·2009
Same author

Action of neuropeptide Y on nociceptive transmission in substantia gelatinosa of the adult rat spinal dorsal horn.

Neuroscience·2005
Same author

[Anti-nociceptive effect of calcitonin on chronic pain associated with osteoporosis].

Clinical calcium·2005
Same author

Functional reorganization of the spinal pain pathways in developmental and pathological conditions.

Novartis Foundation symposium·2004
Same author

Analysis of receptive fields revealed by in vivo patch-clamp recordings from dorsal horn neurons and in situ intracellular recordings from dorsal root ganglion neurons.

Life sciences·2004
Same journal

[A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Recent Advances in the Treatment of HER2-Altered Solid Tumors].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[BRAF-Mutant Solid Tumor].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
See all related articles

Elderly cancer patients can often receive chemotherapy as effectively as younger patients, with similar outcomes for solid tumors. Further research is needed to optimize chemotherapy for older adults, considering individual aging processes.

Area of Science:

  • Geriatric Oncology
  • Cancer Therapeutics
  • Clinical Trials

Context:

  • Increasing cancer incidence in aging populations necessitates tailored treatment strategies.
  • Limited data exists on chemotherapy efficacy and toxicity in elderly cancer patients.
  • Many clinical trials historically excluded older adults with advanced cancer.

Purpose:

  • To review the current understanding of chemotherapy response and toxicity in elderly cancer patients.
  • To evaluate age as a sole criterion for excluding patients from adequate chemotherapy.
  • To highlight the need for further research into geriatric cancer treatment.

Summary:

  • Elderly patients with leukemia and Hodgkin's lymphoma show reduced response and survival rates, often due to treatment-related mortality or insufficient salvage therapy, not chemotherapy resistance.

Related Experiment Videos

  • Older adults with solid tumors generally experience similar chemotherapy response, remission, and survival rates as younger patients.
  • Hematologic toxicity is slightly increased in older patients, but overall toxicity profiles are comparable between age groups.

    • Impact:

    • Suggests that age alone should not be a reason to withhold chemotherapy from elderly cancer patients.
    • Emphasizes that cancer treatment in older adults should be individualized, recognizing aging as a variable process.
    • Underscores the critical need for more extensive research to define the optimal role of chemotherapy in the geriatric oncology population.